[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

World Immunology Drugs Market to Exceed USD 74.1 Bn in 2022, Expects GBI Research in Its New Report Recently Uploaded at MarketPublishers.com

22 Jun 2017 • by Natalie Aster

LONDON – Despite the high degree of uncertainty and failure in research and development of immunological drugs, at present there are 2,054 drugs in active development stage in the immunology pipeline. In the long run, this is likely to spur growth in the immunology drugs market in spite of the expected approval of biosimilars for major blockbuster drugs and as a result erosion of revenues.

In 2015, the revenue of the world’s immunology drugs market was estimated at USD 57.7 billion. Over 2017-2022, it is anticipated to increase at a 3.63% CAGR to exceed USD 74.1 billion in 2022.

Robust growth in the immunology drugs market is attributed to remarkable uptake of interleukin receptor inhibitors, repositioning opportunities and rising prevalence, amid others.

New research report “Global Immunology Drugs Market to 2022 - Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth” prepared by GBI Research provides a comprehensive understanding of the commercial and clinical landscape of the immunology drugs market. It contains relevant info on the disease diagnosis, prognosis, pathogenesis and therapeutics. The study explores the composition of the immunology drugs market across different indications, basing on key molecule types and targets, as well as highlights the main commercial assets and gives data on the top players. Moreover, this topical report offers info on the patient epidemiology and revenues for the immunology drugs market at different geographical levels and also across the leading players and product sectors. The research study reviews generic and premium products, examines the role of these product types in treatment of different immunological disorders, points out the lucrative commercial opportunities and covers co-development and licensing deals trends. Additionally, a future outlook through 2022 for the immunology drugs market is at hand in the report.

Many other topical research reports by GBI Research are offered in the publisher’s online catalogue.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest